HHS sets LINZESS Maximum Fair Price at $136 per 30-day supply starting Jan 2027

IRONWOOD PHARMACEUTICALS INC

MFP for LINZESS (linaclotide) is $136 for a 30-day supply, effective January 1, 2027.
Ironwood says the MFP is in line with company expectations.
LINZESS was selected in the latest round of IRA government price setting.
MFP will become the new Medicare net price for the drug.

item 8.01

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-25-116217

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.